Related Experiment Video
Updated: Aug 3, 2025

Purification of Ubiquitinated p53 Proteins from Mammalian Cells
Published on: March 21, 2022
VprBP/DCAF1 regulates p53 function and stability through site-specific phosphorylation
Nikhil Baban Ghate1, Sungmin Kim1, Roasa Mehmood1
1Department of Biochemistry and Molecular Medicine, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, 90033, USA.
Abstract:
VprBP (also known as DCAF1) is a recently identified kinase that is overexpressed in cancer cells and serves as a major determinant for epigenetic gene silencing and tumorigenesis. The role of VprBP in driving target gene inactivation has been largely attributed to its ability to mediate histone H2A phosphorylation. However, whether VprBP also phosphorylates non-histone proteins and whether these phosphorylation events drive oncogenic signaling pathways have not been explored. Here we report that serine 367 phosphorylation (S367p) of p53 by VprBP is a key player in attenuating p53 transcriptional and growth suppressive activities. VprBP catalyzes p53S367p through a direct interaction with the C-terminal domain of p53. Mechanistically, VprBP-mediated S367p inhibits p53 function in the wake of promoting p53 proteasomal degradation, because blocking p53S367p increases p53 protein levels, thereby enhancing p53 transactivation. Furthermore, abrogation of VprBP-p53 interaction by p53 acetylation is critical for preventing p53S367p and potentiating p53 function in response to DNA damage. Together, our findings establish VprBP-mediated S367p as a negative regulator of p53 function and identify a previously uncharacterized mechanism by which S367p modulates p53 stability.
Insights
VprBP (Vpr-binding protein) phosphorylates p53 at serine 367, inhibiting its tumor-suppressing activity and promoting cancer growth. This phosphorylation event also targets p53 for degradation, highlighting VprBP as a key regulator in tumorigenesis.
Area of Science:
- Molecular Biology
- Cancer Biology
- Biochemistry
Background:
- VprBP (DCAF1) is an overexpressed kinase in cancer, linked to gene silencing and tumorigenesis.
- VprBP's role in histone H2A phosphorylation is established, but its non-histone targets and oncogenic signaling roles are unexplored.
Purpose of the Study:
- To investigate if VprBP phosphorylates non-histone proteins.
- To determine the role of VprBP-mediated phosphorylation in oncogenic signaling pathways.
- To elucidate the mechanism by which VprBP influences p53 function and stability.
Main Methods:
- Investigated VprBP's interaction with p53.
- Analyzed the effect of VprBP on p53 phosphorylation at serine 367 (S367p).
- Assessed the impact of p53S367p on p53 transcriptional activity, growth suppression, and proteasomal degradation.
- Examined the role of p53 acetylation in regulating VprBP-p53 interaction and p53 function.
Main Results:
- VprBP directly interacts with p53's C-terminal domain to catalyze p53S367p.
- VprBP-mediated p53S367p attenuates p53's transcriptional and growth-suppressive activities.
- p53S367p promotes p53 proteasomal degradation, reducing p53 protein levels and transactivation.
- p53 acetylation abrogates VprBP-p53 interaction, preventing p53S367p and enhancing p53 function in response to DNA damage.
Conclusions:
- VprBP acts as a negative regulator of p53 function through S367 phosphorylation.
- VprBP-mediated p53S367p is a novel mechanism that modulates p53 stability and promotes tumorigenesis.
- Targeting the VprBP-p53 interaction offers a potential therapeutic strategy for cancer treatment.
Related Concept Videos
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
Negative Regulator Molecules
Inhibition of Cdk Activity
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...

